RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$191.36

Market cap

$27.76B

P/E Ratio

18.4

Dividend/share

$2.4

EPS

$10.4

Enterprise value

$26.94B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 94

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory ...

Highlights
The price to earnings (P/E) is 52% lower than the 5-year quarterly average of 37.7 and 28% lower than the last 4 quarters average of 25.1
RMD's equity is up by 17% year-on-year and by 2.7% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.resmed.com/
Peers: MDT TMO ELMD INGN

Key stats

What are the main financial stats of RMD

RMD stock price

How has the Resmed stock price performed over time
Intraday
1.54%
1 week
-1.33%
1 month
-8.02%
1 year
-24.82%
YTD
-20.55%
QTD
-14.75%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$5.54B
Gross profit
$3.41B
Operating income
$1.89B
Net income
$1.52B
Gross margin
61.6%
Net margin
27.4%
RMD's operating income is up by 17% YoY and by 4% QoQ
RMD's net income is up by 16% YoY and by 2.3% QoQ
The gross profit has grown by 16% YoY and by 3.8% from the previous quarter
The company's revenue rose by 10% YoY and by 2.6% QoQ

Price vs fundamentals

How does RMD's price correlate with its fundamentals

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
18.4
P/B
4.29
P/S
5.02
EV/EBIT
14.39
EV/EBITDA
12.61
EV/Sales
4.86
The price to earnings (P/E) is 52% lower than the 5-year quarterly average of 37.7 and 28% lower than the last 4 quarters average of 25.1
The EPS has increased by 16% YoY and by 2.5% from the previous quarter
RMD's P/B is 46% below its 5-year quarterly average of 7.8 and 28% below its last 4 quarters average of 5.9
RMD's equity is up by 17% year-on-year and by 2.7% since the previous quarter
The P/S is 37% lower than the 5-year quarterly average of 7.8 and 27% lower than the last 4 quarters average of 6.8
The company's revenue rose by 10% YoY and by 2.6% QoQ

Efficiency

How efficient is Resmed business performance
The company's return on invested capital rose by 27% YoY and by 5% QoQ
The ROS has increased by 10% YoY
Resmed's ROE has decreased by 3.2% YoY

Dividends

What is RMD's dividend history
Dividend details
DPS
$2.4
Dividend yield
1.25%
Payout ratio
23.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Resmed financials performed over time
The company's total assets rose by 16% YoY and by 3.3% QoQ
RMD's total liabilities is up by 13% year-on-year and by 5% since the previous quarter
Resmed's debt is 87% lower than its equity
RMD's equity is up by 17% year-on-year and by 2.7% since the previous quarter
Resmed's debt to equity has decreased by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.